Table 2.
Qualitative analysis of the projects
| Variable | Time period | Total (%) | Project numbers | |||
|---|---|---|---|---|---|---|
| <2004 (4 projects) | 2005–2007 (4 projects) | 2008–2010 (8 projects) | 2011–2013 (13 projects) | |||
| Geographic area covered by the project | ||||||
| Regional | 4 | 3 | 5 | 6 | 18 (62) | 2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 20, 21, 22, 26, 27, 28, 29 |
| National | 0 | 1 | 3 | 6 | 10 (34) | 1, 3, 6, 9, 15, 18, 19, 23, 24, 25 |
| International | 0 | 0 | 0 | 1 | 1 (3) | 12 |
| Area covered by the project | ||||||
| Hospital | 4 | 2 | 5 | 4 | 15 (52) | 2, 4, 5, 8, 11, 13, 17, 18, 20, 21, 22, 26, 27, 28, 29 |
| Community | 0 | 0 | 0 | 6 | 6 (21) | 1, 3, 12, 14, 15, 16 |
| Primary care | 0 | 2 | 1 | 1 | 4 (14) | 6, 7, 9, 10 |
| Other healthcare institutions (different from hospitals or primary care) | 0 | 0 | 1 | 2 | 3 (10) | 19, 24, 25 |
| Clinical trials | 0 | 0 | 1 | 0 | 1 (3) | 23 |
| Type of action promoted by the project | ||||||
| Passive promotion of ADR reporting | 3 | 3 | 6 | 10 | 22 (76) | 4, 5, 6, 8, 9, 10, 11, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 29 |
| Active promotion of ADR reporting | 1 | 1 | 2 | 3 | 7 (24) | 1, 2, 3, 7, 12, 13, 28 |
| Type of software | ||||||
| Web-based | 1 | 3 | 6 | 6 | 16 (55) | 2, 3, 5, 7, 9, 12, 13, 14, 15, 16, 19, 20, 22, 23, 27, 28 |
| System inside the Electronic Health Record | 3 | 1 | 2 | 6 | 12 (41) | 4, 6, 8, 10, 11, 17, 21, 24, 25, 26, 18, 29 |
| Mobile | 0 | 0 | 0 | 1 | 1 (3) | 1 |
| Type of institution promoting the study | ||||||
| Hospital | 2 | 1 | 3 | 3 | 9 (31) | 2, 4, 8, 17, 18, 21, 26, 27, 29 |
| University | 1 | 1 | 3 | 4 | 9 (31) | 5, 10, 11, 12, 13, 19, 20, 24, 25 |
| National institution | 0 | 2 | 0 | 2 | 4 (14) | 1, 9, 15, 22 |
| Regulatory authority | 1 | 0 | 1 | 3 | 5 (17) | 6, 7, 14, 16, 28 |
| Othera | 0 | 0 | 1 | 1 | 2 (7) | 3, 23 |
| Target | ||||||
| Healthcare professionals | 4 | 2 | 7 | 8 | 21 (72) | 4, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 18, 19, 21, 23, 24, 25, 26, 27, 28, 29. |
| Patients | 0 | 2 | 1 | 4 | 7 (24) | 1, 2, 3, 5, 12, 20, 22 |
| Healthcare professionals and patients | 0 | 0 | 0 | 1 | 1 (3) | 15 |
| Type of medicine | ||||||
| All | 4 | 1 | 5 | 11 | 21 (72) | 3, 4, 5, 6, 7, 8, 9, 11, 12, 14, 16, 17, 18, 19, 20, 21, 24, 25, 26, 28, 29 |
| Vaccines | 0 | 2 | 1 | 2 | 5 (17) | 1, 10, 13, 15, 22 |
| Chemotherapy | 0 | 1 | 0 | 0 | 1 (3) | 2 |
| Human albumin | 0 | 0 | 1 | 0 | 1 (3) | 23 |
| Radiopaque agents | 0 | 0 | 1 | 0 | 1 (3) | 27 |
| Type of ADR | ||||||
| All | 4 | 4 | 8 | 11 | 27 (93) | 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 |
| Serious | 0 | 0 | 0 | 2 | 2 (7) | 1, 3 |
a Other institutions are: Clinical trial team (project 23) and website producer (project 3)